Cynata Therapeutics Ltd
ASX:CYP
Cynata Therapeutics Ltd
ASX:CYP
Price:
0.3
AUD
Market Closed
Market Cap:
AU$71.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cynata Therapeutics Ltd
ASX:CYP
|
AU |
|
A
|
Applied Graphene Materials PLC
OTC:APGMF
|
UK |
|
S
|
Steppe Cement Ltd
LSE:STCM
|
MY |
Balance Sheet
Balance Sheet Decomposition
Cynata Therapeutics Ltd
Cynata Therapeutics Ltd
Balance Sheet Decomposition is not available for
Cynata Therapeutics Ltd
Cynata Therapeutics Ltd
Balance Sheet
Cynata Therapeutics Ltd
Cynata Therapeutics Ltd
Currency: AUD
| Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
0
|
0
|
0
|
0
|
1
|
1
|
5
|
5
|
5
|
10
|
12
|
7
|
14
|
27
|
24
|
16
|
6
|
5
|
|
| Cash |
1
|
0
|
0
|
0
|
0
|
1
|
1
|
5
|
5
|
5
|
10
|
12
|
7
|
14
|
27
|
24
|
16
|
6
|
5
|
|
| Short-Term Investments |
0
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
2
|
1
|
1
|
1
|
1
|
1
|
5
|
5
|
5
|
10
|
13
|
7
|
14
|
27
|
24
|
17
|
7
|
5
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
4
|
4
|
4
|
4
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
2
+114%
|
1
-39%
|
1
-12%
|
1
-2%
|
1
-16%
|
2
+75%
|
10
+455%
|
9
-8%
|
9
-1%
|
14
+58%
|
16
+13%
|
12
-24%
|
17
+43%
|
30
+71%
|
27
-11%
|
19
-28%
|
8
-56%
|
7
-14%
|
|
| Liabilities | ||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
2
|
1
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
2
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-20%
|
0
+283%
|
0
-30%
|
0
-22%
|
0
-36%
|
0
-6%
|
0
-53%
|
0
+436%
|
0
+19%
|
0
-13%
|
1
+92%
|
1
+71%
|
1
-46%
|
2
+132%
|
3
+62%
|
2
-13%
|
1
-48%
|
1
+4%
|
|
| Equity | ||||||||||||||||||||
| Common Stock |
3
|
5
|
6
|
7
|
9
|
11
|
12
|
22
|
24
|
29
|
38
|
44
|
48
|
57
|
75
|
75
|
82
|
82
|
90
|
|
| Retained Earnings |
2
|
3
|
5
|
6
|
9
|
10
|
11
|
12
|
16
|
20
|
25
|
29
|
37
|
40
|
47
|
51
|
65
|
74
|
84
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
2
+133%
|
1
-57%
|
1
-3%
|
1
+4%
|
1
-12%
|
2
+93%
|
10
+501%
|
9
-11%
|
9
-2%
|
14
+62%
|
15
+11%
|
11
-29%
|
17
+53%
|
28
+69%
|
24
-16%
|
17
-30%
|
7
-57%
|
6
-17%
|
|
| Total Liabilities & Equity |
1
N/A
|
2
+114%
|
1
-39%
|
1
-12%
|
1
-2%
|
1
-16%
|
2
+75%
|
10
+455%
|
9
-8%
|
9
-1%
|
14
+58%
|
16
+13%
|
12
-24%
|
17
+43%
|
30
+71%
|
27
-11%
|
19
-28%
|
8
-56%
|
7
-14%
|
|
| Shares Outstanding | ||||||||||||||||||||
| Common Shares Outstanding |
3
|
4
|
4
|
5
|
7
|
20
|
25
|
55
|
66
|
73
|
90
|
95
|
102
|
117
|
143
|
143
|
180
|
180
|
226
|
|
Switch to:
Switch to:
See Also
Discover More
